Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Healthy Subjects

Interventions

DRUG

Selexipag for intravenous use

Selexipag was reconstituted in sterile 0.9% w/v NaCl before infusion via an infusion pump at a rate of 2.5 µg/min.

DRUG

Selexipag for oral use

Tablet containing 200 µg of selexipag